Wang, HuiDivaris, KimonPan, BohuLi, XiaofeiLim, Jong-HyungSaha, GundappaBarovic, MarkoGiannakou, DanaiKorostoff, Jonathan M.Bing, YuSen, SouvikMoss, KevinWu, DiBeck, James D.Ballantyne, Christie M.Natarajan, PradeepNorth, Kari E.Netea, Mihai G.Chavakis, TriantafyllosHajishengallis, George2024-09-182024-09-182024Wang H, Divaris K, Pan B, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024;187(14):3690-3711.e19. doi:10.1016/j.cell.2024.05.003https://hdl.handle.net/1805/43397Clonal hematopoiesis of indeterminate potential (CHIP) arises from aging-associated acquired mutations in hematopoietic progenitors, which display clonal expansion and produce phenotypically altered leukocytes. We associated CHIP-DNMT3A mutations with a higher prevalence of periodontitis and gingival inflammation among 4,946 community-dwelling adults. To model DNMT3A-driven CHIP, we used mice with the heterozygous loss-of-function mutation R878H, equivalent to the human hotspot mutation R882H. Partial transplantation with Dnmt3aR878H/+ bone marrow (BM) cells resulted in clonal expansion of mutant cells into both myeloid and lymphoid lineages and an elevated abundance of osteoclast precursors in the BM and osteoclastogenic macrophages in the periphery. DNMT3A-driven clonal hematopoiesis in recipient mice promoted naturally occurring periodontitis and aggravated experimentally induced periodontitis and arthritis, associated with enhanced osteoclastogenesis, IL-17-dependent inflammation and neutrophil responses, and impaired regulatory T cell immunosuppressive activity. DNMT3A-driven clonal hematopoiesis and, subsequently, periodontitis were suppressed by rapamycin treatment. DNMT3A-driven CHIP represents a treatable state of maladaptive hematopoiesis promoting inflammatory bone loss.en-USPublisher PolicyDNMT3AT cellsArthritisBone marrowClonal hematopoiesis of indeterminate potentialHematopoietic stem and progenitor cellsInflammationNeutrophilsOsteoclastogenesisPeriodontitisArticle